State Of Wyoming Edgewise Therapeutics, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.67 - $9.87 $187 - $325	-33 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$9.1 - $18.97 $54 - $113	6 Added 22.22%	33 $0
Q4 2021 Feb 11, 2022	SELL	$14.41 - $22.41 $28 - $44	-2 Reduced 6.9%	27 $0
Q3 2021 Feb 11, 2022	SELL	$14.11 - $24.1 $183 - $313	-13 Reduced 30.95%	29 $0
Q2 2021 Feb 11, 2022	BUY	$21.33 - $30.25 $895 - $1,270	42 New	42 $1,000

129

76.3M

14.7K

14.8K

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $1.14B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.